Puget Sound Business Journal: Seattle biotech Kineta to go public in reverse merger deal with Yumanity Therapeutics On June 7, 2022 / Biotech Industry News
GeekWire: Seattle biotech Kineta will go public in deal with neurosciences company Yumanity Therapeutics On June 6, 2022 / Biotech Industry News
Kineta Announces Reverse Merger with NASDAQ listed Yumanity Therapeutics (YMTX) On June 6, 2022 / Biotech Industry News
Life Sciences Review Selects Kineta as Top Biotech Startup of 2022 On May 26, 2022 / Biotech Industry News
Pharma Tech Outlook Top 10 Immunotherapy Companies 2020 On September 15, 2020 / Biotech Industry News
Kineta Named Immunotherapy Company of the Year by Pharma Tech Outlook On August 31, 2020 / Biotech Industry News
Shawn Iadonato Named as One of the Top 50 Healthcare Technology CEOs of 2020 On May 20, 2020 / Biotech Industry News
Seattle Biotech CEO Keeps A Watchful Eye on the Market for Potential IPO On May 13, 2020 / Biotech Industry News
After a run of CTLA-4 combo failures, scientists spotlight a way to make it work — in select patients On September 17, 2019 / Biotech Industry News
